The diagnostic accuracy of 18F-Fluorodeoxyglucose PET/CT in patients with gynecological malignancies

被引：55

作者：

Grisaru, D

Almog, B

Levine, C

Metser, U

Fishman, A

Lerman, H

Lessing, JB

Even-Sapir, E

机构：

[1] Tel Aviv Sourasky Med Ctr, Dept Obstet & Gynecol, IL-64239 Tel Aviv, Israel

[2] Tel Aviv Sourasky Med Ctr, Dept Radiol, IL-64239 Tel Aviv, Israel

[3] Tel Aviv Sourasky Med Ctr, Dept Nucl Med, IL-64239 Tel Aviv, Israel

[4] Tel Aviv Univ, Sackler Fac Med, Meir Med Ctr, Dept Obstet & Gynecol, IL-69978 Tel Aviv, Israel

来源：

GYNECOLOGIC ONCOLOGY | 2004年 / 94卷 / 03期

关键词：

positron emission tomography/computerized tomography; staging; follow-up;

D O I：

10.1016/j.ygyno.2004.05.053

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Objective. To evaluate the diagnostic accuracy of integrated positron emission tomography/computerized tomography (PET/CT) in patients with gynecological cancer. Methods. Fifty-three consecutive patients with gynecologic malignancies were included. The patients were referred to our tertiary center to undergo a PET/CT scan. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of PET/CT were compared with the conventional imaging assessments [CT, magnetic resonance imaging (MRI) and ultrasonography (US)]. Results. All tested values were higher for PET/CT than those for the conventional modalities: sensitivity 0.97 vs. 0.40, specificity 0.94 vs. 0.65, PPV 0.97 vs. 0.70, and NPV 0.94 vs. 0.34, respectively. Conclusion. PET/CT is a reliable modality for assessing the extent of disease in patients with gynecologic malignancy. (C) 2004 Elsevier Inc. All rights reserved.

引用

页码：680 / 684

页数：5

共 20 条

[1] PET imaging in oncology [J].